Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2023-07-24 00:00:00 ET · period of report 2023-07-20 · accession 0001104659-23-083499 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-24 | 2023-07-20 | OBIO | Connealy Pamela Ann | Dir | A - Grant | $0.00 | +11.7K | 15.9K | +275% | $0 |
| D | 2023-07-24 | 2023-07-20 | OBIO | Connealy Pamela Ann | Dir | A - Grant | $0.00 | +17.5K | 17.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share ("Common Stock") | 2023-07-20 | A | A | 11,667 | $0.00 | 15,913 | D | — | — | (F1) Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on the first anniversary of the grant date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-07-20 | A | A | 17,500 | $0.00 | 17,500 | D | $7.42 · 2024-07-20 to 2033-07-20 | 17,500 Common Stock |